TITLE

Cardiac Anesthesia & Surgery: Past, Present & Future

AUTHOR(S)
Cheng, Davy C. H.
PUB. DATE
April 2007
SOURCE
Revista Mexicana de Anestesiologia;abr-jun2007 supplement, Vol. 30, pS55
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a history of the development of cardiac anesthesia and surgery. In 1915, Jay McLean discovered the anticogulant effect of heparin and in 1927, Charles Best succeeded in purifying heparin. The first successful ligation of a patent ductus on a seven-year old female patient was performed by Robert Gross of Boston Children's Hospital in 1938.
ACCESSION #
27451181

 

Related Articles

  • Postoperative care: Avoiding complications. Frost, Elizabeth A. M. // Revista Mexicana de Anestesiologia;abr-jun2007 supplement, Vol. 30, pS43 

    The article focuses on the avoidance of complications in postoperative care. The common postoperative complications overlooked by anesthesiologists include cardiorespiratory problems, heparin-induced thrombocytopenia (HIT) and postoperative nausea and vomiting (PONV). The case of a 68-year-old...

  • Continue anticoagulation for up to 8 weeks after hip replacement surgery.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p44 

    Summarizes the study `Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis Against Venous Thromboembolism After Total Hip Replacement,' by D. Bergqvist and colleagues, published in the September 5, 1996 issue of `New England Journal of Medicine.' Three strategies for the post-discharge care...

  • Home-Monitoring von Patienten nach künstlichem Herzklappenersatz. Fritzsche, Dirk; Eitz, Thomas; Horstkotte, Dieter; Körfer, Reiner // Herz;Sep2007, Vol. 32 Issue 6, p491 

    Despite enormous progress concerning material and design, patients with artificial heart valves still face a considerable risk of serious complications (e. g., hemorrhage, thromboemboli, redos) which sum up to 4.9– 22.4% for the first 10 postoperative years depending on type and position...

  • Topical Issues in Venous Thromboembolism. Rico, José Ignacio Abad; Pitarch, Juan Vicente Llau; Fernández, José Antonio Páramo // Drugs;2010 Supplement 2, Vol. 70, p11 

    Despite clear guidelines and the availability of effective treatments, venous thromboembolism (VTE) remains relatively common, particularly in the hospital setting. This paper reviews topical issues in VTE, in terms of treatments, data and guidelines. Existing anticoagulants have several...

  • New Anticoagulants for the Prevention of Thromboembolism. Lepic, Kylie; Crowther, Mark // Current Pharmaceutical Design;10/21/2010, Vol. 16 Issue 31, p3472 

    No abstract available.

  • Portal Vein Thrombosis After Laparoscopic and Open Splenectomy. Vecchio, Rosario; Cacciola, Emma; Cacciola, Rossella R.; Marchese, Salvatore; Intagliata, Eva // Journal of Laparoendoscopic & Advanced Surgical Techniques;Jan/Feb2011, Vol. 21 Issue 1, p71 

    Introduction: Portal vein thrombosis (PVT) could be a life-threatening complication after splenectomy if not diagnosed promptly and treated properly. Risk factors of PVT are not completely clarified. Spleen size and underlying hematologic diseases are main potential risk factors for this...

  • Low Molecular Weight Heparin: Current Evidence for Its Application in Orthopaedic Surgery. Kalyani, Bharati S.; Roberts, Craig S. // Current Vascular Pharmacology;Jan2011, Vol. 9 Issue 1, p19 

    No abstract available.

  • Antiplatelet drugs, anticoagulants and elective surgery. Merriman, Eileen; Tran, Huyen // Australian Prescriber;Oct2011, Vol. 34 Issue 5, p139 

    There is an increased risk of bleeding when patients taking anticoagulant or antiplatelet drugs require surgery. This risk must be balanced against the risk of harm if treatment is stopped. For many minor procedures aspirin or warfarin can be continued. Patients having non-cardiac surgery may be...

  • Long-Term Outcomes with Bare Metal Stents. Boyle, Andrew // Clinical Cardiology Alert;Feb2008, Vol. 27 Issue 2, p11 

    Recently, there has been considerable concern regarding the long-term safety of drug-eluting stents. Reports of late (> 30 days post implantation), and very late (> 1 year post implantation), stent thrombosis have raised concern over these devices, and there has been a corresponding resurgence...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics